NM_032797.6:c.662G>A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032797.6(AIFM2):c.662G>A(p.Arg221Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00017 in 1,614,180 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032797.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AIFM2 | ENST00000307864.3 | c.662G>A | p.Arg221Gln | missense_variant | Exon 7 of 9 | 1 | NM_032797.6 | ENSP00000312370.1 | ||
AIFM2 | ENST00000373248.5 | c.662G>A | p.Arg221Gln | missense_variant | Exon 6 of 9 | 1 | ENSP00000362345.1 | |||
AIFM2 | ENST00000613322.4 | c.662G>A | p.Arg221Gln | missense_variant | Exon 7 of 9 | 5 | ENSP00000478931.1 | |||
AIFM2 | ENST00000482166.1 | n.499G>A | non_coding_transcript_exon_variant | Exon 3 of 4 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000276 AC: 42AN: 152184Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000262 AC: 66AN: 251480Hom.: 0 AF XY: 0.000302 AC XY: 41AN XY: 135916
GnomAD4 exome AF: 0.000159 AC: 233AN: 1461878Hom.: 0 Cov.: 34 AF XY: 0.000166 AC XY: 121AN XY: 727242
GnomAD4 genome AF: 0.000269 AC: 41AN: 152302Hom.: 0 Cov.: 33 AF XY: 0.000255 AC XY: 19AN XY: 74470
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.662G>A (p.R221Q) alteration is located in exon 7 (coding exon 6) of the AIFM2 gene. This alteration results from a G to A substitution at nucleotide position 662, causing the arginine (R) at amino acid position 221 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at